Biotechnology Analysis & Statistics, November 2014 (p40)

24/7 Customer Support

Talk to Louis

+1 718 618 4302

Publishers

All regions

1171-1200 of about 4 200 reports

Purchase Reports From Reputable Market Research Publishers

Chemokine Therapeutics Corp. (CTI) - Strategic SWOT Analysis Review

Chemokine Therapeutics Corp. (CTI) - Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2014
  • by Global Data

Summary Chemokine Therapeutics Corp. (Chemokine Therapeutics) is a publicly held biotechnology company. It is engaged in the discovery and develops peptide analogs of chemokines for cancer treatment and ...

  • Industries : Biological Therapy, Therapy
MWG-Biotech AG - Strategic SWOT Analysis Review

MWG-Biotech AG - Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2014
  • by Global Data

Summary MWG-Biotech AG (MWG) is a biotechnology company. The company manufactures and markets biomolecules and apparatus for use in molecular biology. Its products include PCR primer, cloning oligo, qPCR ...

  • Industries : Biotechnology, Genomics
Dendritic Cell and CAR-T Therapies Market, 2014 - 2024

Dendritic Cell and CAR-T Therapies Market, 2014 - 2024

  • $ 1 899
  • Industry report
  • November 2014
  • by Roots Analysis Private Ltd.

INTRODUCTION Cancer is known to be one of the leading causes of death worldwide. The field of oncology is vast and comprises several indications, including some rare / orphan forms. Although oncology continues ...

  • Industries : Pharmaceutical, Biological Therapy, Therapy, Biotechnology, Motor Vehicle, Pathology, Hospitality, Hospitality, Automotive
  • Countries : United States
Ibex Technologies Inc.

Ibex Technologies Inc.

  • $ 55
  • Company report
  • November 2014
  • by Wright Investors' Service

A textual analysis of the financial results for Ibex Technologies Inc. compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio ...

  • Countries : World
Synthetic Biology Market by Tool, Technology (Bioinformatics, Nanotechnology, Gene Synthesis, Cloning & Sequencing), Application (Biofuels, Pharmaceuticals, Biomaterials, Bioremediation) - Global Forecast to 2018

Synthetic Biology Market by Tool, Technology (Bioinformatics, Nanotechnology, Gene Synthesis, Cloning & Sequencing), Application (Biofuels, Pharmaceuticals, Biomaterials, Bioremediation) - Global Forecast to 2018

  • $ 4 650
  • Industry report
  • November 2014
  • by MarketsandMarkets

The synthetic biology market is rapidly evolving, with various technological advancements that have resulted in a paradigm shift within the market. This has resulted in advanced production of synthetic ...

  • Industries : Genetically Modified Organism, Biotechnology
  • Countries : World, United States, Europe, North America
Provenance Biopharmaceuticals Corp. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Provenance Biopharmaceuticals Corp. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • November 2014
  • by Global Data

Summary Provenance Biopharmaceuticals Corp. (Provenance) is a biopharmaceutical company. The company develops immunotherapeutics to treat cancer and other serious life threatening diseases. It develops ...

  • Industries : Biopharmaceutical, Healthcare
  • Countries : United States
Raven biotechnologies, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Raven biotechnologies, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • November 2014
  • by Global Data

Summary Raven biotechnologies, Inc. (Raven biotechnologies) is a biotechnology company that is engaged in the development, manufacture and marketing of in-vitro diagnostic products. The company develops ...

  • Industries : Biotechnology
Evolutionary Genomics, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Evolutionary Genomics, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • November 2014
  • by Global Data

Summary Evolutionary Genomics, Inc. (EG) is a biotechnology company. The company develops and distributes genes that are responsible for increased crop yield, pest and disease resistance, salt tolerance ...

Golden Biotechnology Corp. (4132) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Golden Biotechnology Corp. (4132) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • November 2014
  • by Global Data

Summary Golden Biotechnology Corp. (Golden Biotech) is a biotechnology company. The company develops and commercializes drugs and herbal supplements to prevent and treat diseases. It discovers new drugs ...

  • Industries : Biotechnology
Global Oncology Biosimilars Market 2014-2018

Global Oncology Biosimilars Market 2014-2018

  • $ 2 500
  • Industry report
  • November 2014
  • by Infiniti Research Limited

About Oncology Biosimilars Biosimilars are follow-on versions of biological medicines that are developed after the expiry of the patent protection on the original product. Biosimilar medicines have a mechanism ...

  • Industries : Generic Drug, Pharmaceutical
  • Countries : World
Physician Views: Will next-generation long-acting insulins prove compelling?

Physician Views: Will next-generation long-acting insulins prove compelling?

  • $ 681
  • Industry report
  • November 2014
  • by Firstword Pharma

In the second of two diabetes-focused Physician Views polls being run by FirstWord Pharma PLUS this week (see also Physician Views: What opportunity for biosimilar basal insulin?), we are polling US and ...

  • Industries : Biopharmaceutical
  • Countries : Europe
China Recombinant Protein Drug Industry Report, 2014-2017

China Recombinant Protein Drug Industry Report, 2014-2017

  • $ 2 500
  • Industry report
  • November 2014
  • by Research In China

The Chinese recombinant protein drug market has been expanding rapidly owing to the improvement of demand rigidity, consumption ability and the like. During 2005-2013, sales of recombinant protein drugs ...

  • Industries : Drug and Medication
  • Countries : China
Ipsen Biopharmaceuticals, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Ipsen Biopharmaceuticals, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • November 2014
  • by Global Data

Summary Ipsen Biopharmaceuticals, Inc., (Ipsen), formerly known as Tercica, Inc., is a biotechnology company. It identifies and commercializes products in therapy areas such as, endocrinology and neurology. ...

  • Industries : Biopharmaceutical
Ontario Genomics Institute - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Ontario Genomics Institute - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • November 2014
  • by Global Data

Summary Ontario Genomics Institute (OGI) is a research and development organization. The organization provides life science research and development services. It handles genomics projects and develops ...

  • Industries : Genomics
  • Countries : Canada
Keryx Biopharmaceuticals, Inc. (KERX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Keryx Biopharmaceuticals, Inc. (KERX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • November 2014
  • by Global Data

Summary Keryx Biopharmaceuticals, Inc. (Keryx) is a biopharmaceutical company, It is engaged in acquiring, developing and commercializing pharmaceuticals products.Currently the company’s only product ...

  • Industries : Biopharmaceutical, Pharmaceutical
Intracerebral Hemorrhage - Pipeline Review, H2 2014

Intracerebral Hemorrhage - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • November 2014
  • by Global Markets Direct

Intracerebral Hemorrhage - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Intracerebral Hemorrhage - Pipeline Review, H2 2014’, provides an overview of the Intracerebral Hemorrhage’s ...

  • Industries : Pharmaceutical, Pathology
  • Countries : United States, World
Hypoglycemia - Pipeline Review, H2 2014

Hypoglycemia - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • November 2014
  • by Global Markets Direct

Hypoglycemia - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Hypoglycemia - Pipeline Review, H2 2014’, provides an overview of the Hypoglycemia’s therapeutic pipeline. This report ...

  • Industries : Pathology, Pharmaceutical, Biopharmaceutical
  • Countries : United States
Oneness Biotech Co., Ltd. (4743) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Oneness Biotech Co., Ltd. (4743) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • November 2014
  • by Global Data

Summary Oneness Biotech Co., Ltd (Oneness Biotech) is a biopharmaceutical company. It focuses on the research and development of new drugs for unmet medical needs. The pipeline portfolio of the company ...

  • Industries : Biotechnology, Pathology
Eurocine Vaccines AB (EUCI) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Eurocine Vaccines AB (EUCI) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • November 2014
  • by Global Data

Summary Eurocine Vaccines AB (Eurocine) is a clinical stage development company. It develops patent protected nasal vaccines for influenza and pneumococci. The company’s development pipeline consists ...

  • Industries : Biopharmaceutical, Drug and Medication
Epstein-Barr Viral Infections - Pipeline Review, H2 2014

Epstein-Barr Viral Infections - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • November 2014
  • by Global Markets Direct

Epstein-Barr Viral Infections - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Epstein-Barr Viral Infections - Pipeline Review, H2 2014’, provides an overview of the Epstein-Barr Viral ...

  • Industries : Pathology, Pharmaceutical
  • Countries : United States
Fabry Disease - Pipeline Review, H2 2014

Fabry Disease - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • November 2014
  • by Global Markets Direct

Fabry Disease - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Fabry Disease - Pipeline Review, H2 2014’, provides an overview of the Fabry Disease’s therapeutic pipeline. This report ...

  • Industries : Pathology, Pharmaceutical, Drug and Medication
  • Countries : United States
Grass Pollen Allergy - Pipeline Review, H2 2014

Grass Pollen Allergy - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • November 2014
  • by Global Markets Direct

Grass Pollen Allergy - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Grass Pollen Allergy - Pipeline Review, H2 2014’, provides an overview of the Grass Pollen Allergy’s therapeutic ...

  • Industries : Drug and Medication, Pharmaceutical
  • Countries : World
Enterovirus Infections - Pipeline Review, H2 2014

Enterovirus Infections - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • November 2014
  • by Global Markets Direct

Enterovirus Infections - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Enterovirus Infections - Pipeline Review, H2 2014’, provides an overview of the Enterovirus Infections’s therapeutic ...

  • Industries : Pathology, Drug and Medication, Biopharmaceutical, Pharmaceutical, Biotechnology
  • Countries : World, China
West Nile Virus Infections - Pipeline Review, H2 2014

West Nile Virus Infections - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • November 2014
  • by Global Markets Direct

West Nile Virus Infections - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘West Nile Virus Infections - Pipeline Review, H2 2014’, provides an overview of the West Nile Virus Infections’s ...

  • Industries : Biopharmaceutical, Drug and Medication, Research and Development, Pathology, Pharmaceutical
  • Countries : United States
Infectitious Diarrhea - Pipeline Review, H2 2014

Infectitious Diarrhea - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • November 2014
  • by Global Markets Direct

Infectitious Diarrhea - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Infectitious Diarrhea - Pipeline Review, H2 2014’, provides an overview of the Infectitious Diarrhea’s therapeutic ...

  • Industries : Pathology, Pharmaceutical
  • Countries : United States
Ragweed Allergy - Pipeline Review, H2 2014

Ragweed Allergy - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • November 2014
  • by Global Markets Direct

Ragweed Allergy - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Ragweed Allergy - Pipeline Review, H2 2014’, provides an overview of the Ragweed Allergy’s therapeutic pipeline. This ...

  • Industries : Biopharmaceutical, Drug and Medication, Pharmaceutical
  • Countries : World, United States
Male Infertility - Pipeline Review, H2 2014

Male Infertility - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • November 2014
  • by Global Markets Direct

Male Infertility - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Male Infertility - Pipeline Review, H2 2014’, provides an overview of the Male Infertility’s therapeutic pipeline. ...

  • Industries : General Medicine and Specialty Medicine
  • Countries : World
Microscopic Polyangiitis (MPA) - Pipeline Review, H2 2014

Microscopic Polyangiitis (MPA) - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • November 2014
  • by Global Markets Direct

Microscopic Polyangiitis (MPA) - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Microscopic Polyangiitis (MPA) - Pipeline Review, H2 2014’, provides an overview of the Microscopic Polyangiitis ...

  • Industries : Pathology, Pharmaceutical, Biopharmaceutical
  • Countries : World, United States
Wegener%s Granulomatosis - Pipeline Review, H2 2014

Wegener%s Granulomatosis - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • November 2014
  • by Global Markets Direct

Wegener's Granulomatosis - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Wegener's Granulomatosis - Pipeline Review, H2 2014’, provides an overview of the Wegener's Granulomatosis’s ...

  • Industries : Pathology, Pharmaceutical
  • Countries : World
DNA & DNA Forensic Laboratories in the US - Industry Market Research Report

DNA & DNA Forensic Laboratories in the US - Industry Market Research Report

  • $ 1 020
  • Industry report
  • November 2014
  • by Ibisworld

DNA & DNA Forensic Laboratories In the five years to 2014, the DNA and DNA Forensic Laboratories industry will benefit from improved accessibility and declining prices, which have made DNA testing more ...

  • Industries : Genomics
  • Countries : United States

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.